Drug and Medication Analysis & Statistics in Europe Countries, January 2015

1-50 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: The EU/IMF economic rescue package, approved in May 2011, has widespread implications for the pharmaceutical segment, including changes to reimbursement, the obligation to prescribe by active ...

  • Industries : Drug and Medication
  • Countries : Portugal
Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. ...

  • Industries : Drug and Medication
  • Countries : Greece
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Moldova’s small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination for investment. However, it is the most liberal country in the Commonwealth ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Demographic considerations – in combination with concerted cost-containment pressures that form part of fiscal austerity measures – will continue to hamper the development of the Lithuanian ...

  • Industries : Drug and Medication
  • Countries : Lithuania
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

The Czech Republic retains its pole position in BMI’s Q111 Regional Business Environment Ratings (BERs) for Emerging Europe. In our global table, the Czech Republic moved upward, placing 12th, now being ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to receive ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Renewed liberalisation of Russia’s pharmaceutical industry could follow the final approval of the country’s membership of the World Trade Organisation (WTO) at the end of 2011. Liberalisation ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The expected growth of Belgium’s ageing population will have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than young people due ...

  • Industries : Drug and Medication
  • Countries : Belgium
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. ...

  • Industries : Drug and Medication
  • Countries : Belarus
Finland Pharmaceuticals and Healthcare Report Q1 2015

Finland Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Finland, like many other Western countries, has a mature pharmaceutical market where growth is slowing. Although an ageing population will drive the demand ...

  • Industries : Drug and Medication
  • Countries : Finland
United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

United Kingdom Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare markets of the United Kingdom are driven by government spending in the form of the National Health System (NHS), which accounts ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: It is our view that the Swiss economy will record slower growth in 2012. This may lead to the implementation of more austerity measures which will impact the publicly funded pharmaceuticals and ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Poland Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Poland Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Poland is an important pharmaceutical industry in Central and Eastern Europe (CEE), and is a relatively well-developed industry compared with those to the east. Poland’s total drug expenditure and projected ...

  • Industries : Drug and Medication
  • Countries : Poland
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: We continue to see strong short and medium-term growth potential for the Ukrainian pharmaceutical industry, with the caveat that the industry faces severe and ever-present economic risks strongly ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Austria Pharmaceuticals and Healthcare Report Q1 2015

Austria Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. While the ...

  • Industries : Drug and Medication
  • Countries : Austria
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: While we lowered our projections for Hungary's pharmaceutical industry in response to the government's structural reform programme at the start of 2011, we continue to believe the reported magnitude ...

  • Industries : Drug and Medication
  • Countries : Hungary
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Latvia’s attractiveness to multinationals will continue to be negatively impacted by the government’s cost-containment measures and the wider macroeconomic performance, especially as much ...

  • Industries : Drug and Medication
  • Countries : Latvia
Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the industry . BMI believes the current form of the legislation is overly simplistic and punishes ...

  • Industries : Drug and Medication
  • Countries : Romania
Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Under pressure from jittery financial industries, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio Berlusconi. ...

  • Industries : Drug and Medication
  • Countries : Italy
Sweden Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Sweden’s pharmaceutical industry is expected to grow weakly over the coming years as the government’s attempts to contain health care costs focus on pharmaceutical expenditure. Having said ...

  • Industries : Drug and Medication
  • Countries : Sweden
Croatia Pharmaceuticals and Healthcare Report Q1 2015

Croatia Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Drug shortages have been reported for certain drugs such as antibiotics as their prices make them unprofitable for manufacturers. The HZZO continues to face ...

  • Industries : Drug and Medication
  • Countries : Croatia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Although Slovenia is a small pharmaceutical industry, the country boasts a well-developed healthcare system and solid infrastructure, propped up by high per capita spending on healthcare. However, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Moldova is projection to deliver a solid US dollar compound annual growth rate (CAGR) of just under 8% for the period from 2010 to 2015, below its rate earlier this decade. The industry is generally ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Switzerland
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Finland Pharmaceuticals and Healthcare Report Q4 2104

Finland Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will place a greate ...

  • Industries : Drug and Medication
  • Countries : Finland
Greece Pharmaceuticals and Healthcare Report Q4 2104

Greece Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over the remainder of 2014. The government will seek to reduce public spending ...

  • Industries : Drug and Medication
  • Countries : Greece
Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth ...

  • Industries : Drug and Medication
  • Countries : Czech Republic

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.